Alpha interferon therapy of chronic delta hepatitis: a pilot study
Di Bisceglie, A.M.; Negro, F.; Smedile, A.; Bergmann, K.; Hoofnagle, J.H.
Progress in Clinical and Biological Research 364: 393-397
1991
ISSN/ISBN: 0361-7742 PMID: 2020714 Document Number: 387606
Document emailed within 1 workday
Related Documents
Gaudin, J.L.; Trépo, C. 1993: Therapy of chronic delta hepatitis with alpha- and beta-interferon Progress in Clinical and Biological Research 382: 345-352Tran, A.; Longo, F.; Saint-Paul, M.C.; Doglio, A.; Benzaken, S.; Rampal, P. 2000: Long-term lamivudine therapy for interferon-alpha- and/or adenine arabinoside monophosphate-resistant chronic hepatitis B infection. Results of a pilot study Gastroenterologie Clinique et Biologique 24(12): 1234-1235
Marinucci, G.; Hassan, G.; Di Giacomo, C.; Barlattani, A.; Costa, F.; Rasshofer, R.; Roggendorf, M. 1991: Long term treatment of chronic delta hepatitis with alpha recombinant interferon Progress in Clinical and Biological Research 364: 405-410
Gunsar, F.; Akarca, U.S.; Ersoz, G.; Kobak, A.C.; Karasu, Z.; Yuce, G.; Ilter, T.; Batur, Y. 2005: Two-year interferon therapy with or without ribavirin in chronic delta hepatitis Antiviral Therapy 10(6): 721-726
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Fujisawa, T.; Inui, A.; Komatsu, H.; Miyagawa, Y.; Onoue, M. 1998: Interferon-alpha therapy for children with chronic hepatitis C Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi Zhonghua Minguo Xiao Er Ke Yi Xue Hui 39(3): 146-149
Yamamoto, H.; Hayashi, E.; Nakamura, H.; Kimura, Y.; Ito, H.; Kambe, H. 1992: Interferon therapy for non-A, non-B hepatitis: a pilot study and review of the literature Hepato-Gastroenterology 39(5): 377-380
Alscher, D.M.; Bode, J.C. 1992: Therapy of acute and chronic viral hepatitis C (non-A, non-B) with interferon-alpha Medizinische Klinik 87(10): 532-539
Niederau, C.; Heintges, T.; Niederau, M.; Stremmel, W.; Strohmeyer, G. 1993: Selection of patients with chronic hepatitis B for therapy with alpha-interferon Zeitschrift für Arztliche Fortbildung 87(4): 273-278
Mizoi, Y.; Kaneko, H.; Oharazawa, A.; Kuroiwa, H. 1997: Parkinsonism in a patient receiving interferon alpha therapy for chronic hepatitis C Rinsho Shinkeigaku 37(1): 54-56
Sampliner, R.E. 1991: Long-term effect of alpha-interferon therapy in chronic hepatitis B American Journal of Gastroenterology 86(12): 1838-1839
Bresci, G.; Parisi, G.; Banti, S.; Bertoni, M. 1993: Therapy of active chronic hepatitis with recombinant alpha 2b-interferon: an 18 month follow-up European Journal of Medicine 2(6): 349-352
Panasiuk, A.; Prokopowicz, D.; Zak, J. 2004: Immunological response in chronic hepatitis C virus infection during interferon alpha therapy Hepato-Gastroenterology 51(58): 1088-1092
Castilla, A.; Castilla, I.; Prieto, J. 1993: Alpha-Interferon therapy for hepatitis C virus chronic infection with mixed cryoglobulinemia American Journal of Gastroenterology 88(3): 466-467
Orságová, I.; RoŽnovský, Lěk.; Petroušová, L.; Konečná, M.; Kabieszová, Lše.; Šafarčík, K.; Kloudová, A. 2014: Thyroid dysfunction during interferon alpha therapy for chronic hepatitis B and C - twenty years of experience Klinicka mikrobiologie a infekcni lekarstvi 20(3): 92-97
Kuloğlu, Z.; Kansu, A.; Erden, E.; Girgin, N. 2010: Efficacy of combined interferon alpha and long-term lamivudine therapy in children with chronic hepatitis B Turkish Journal of Pediatrics 52(5): 457-463
Demir, G.; Ozguroglu, M.; Sayhan, N.; Molinas-Mandel, N.; Demirelli, F.; Buyukunal, E.; Tuzuner, N.; Serdengecti, S.; Berkarda, B. 1999: Immunomodulating therapy with rIL-2 and interferon alpha-induces in vivo expression of Bcl-2, Fas (APO-1/CD95), and Fas ligand on peripheral lymphocytes (a pilot study) Anticancer Research 19(4c): 3517-3520
Fedorchenko, S.V. 1994: Can chronic hepatitis B patients overcome resistance to antiviral therapy due to production of antibodies to recombinant alpha-2-interferon? Voprosy Virusologii 39(5): 218-220
Carreño, V.; Porres, J.C.; Ruiz-Moreno, M.; Gutiez, J.; Bartolomé, F.J. 1991: A controlled study of treatment with recombinant interferon alpha of chronic hepatitis due to the B virus in childhood Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 79(1): 24-28